SoftOx Solutions Investor Relations Material
Latest events
Investor Update
SoftOx Solutions
Q4 2024
26 Mar, 2025
Q3 2024
27 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SoftOx Solutions
Access all reports
SoftOx Solutions operates as a biotech company. The company focuses on the development of medical devices for diagnostics and treatment of tissue injury and other diseases. Its products include SoftOx Endo, which is used to treat tissue deterioration in the esophagus; and SoftOx Burn, which is used to prevent scarring following burn injuries.
Key slides for SoftOx Solutions
Investor Update
SoftOx Solutions
Investor Update
SoftOx Solutions
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
SOFTX
Country
🇳🇴 Norway